CELLULAR BIOMEDICINE GROUP, INC. — Net Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/7cac58f1-c615-443e-888f-3003f96fc3ec/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2019 | $-50.0M | 2019-01-01 – 2019-12-31 | evidence 0001654954-20-002065 |
| FY 2018 | $-38.9M | 2018-01-01 – 2018-12-31 | evidence 0001654954-19-001756 |
| FY 2017 | $-25.5M | 2017-01-01 – 2017-12-31 | evidence 0001654954-18-002152 |
| FY 2016 | $-28.2M | 2016-01-01 – 2016-12-31 | evidence 0001654954-17-001934 |
| FY 2015 | $-19.4M | 2015-01-01 – 2015-12-31 | evidence 0001354488-16-006531 |
| FY 2014 | $-15.5M | 2014-01-01 – 2014-12-31 | evidence 0001354488-15-001428 |
| FY 2013 | $-13.8M | 2013-01-01 – 2013-12-31 | evidence 0001354488-14-001924 |
| FY 2012 | $-7.0M | 2012-01-01 – 2012-12-31 | evidence 0001354488-14-001924 |
| FY 2011 | $-516.4k | 2011-01-01 – 2011-12-31 | evidence 0001354488-13-004464 |
| FY 2010 | $-175.0k | 2010-01-01 – 2010-12-31 | evidence 0001354488-13-004464 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CELLULAR BIOMEDICINE GROUP, INC. — all facts · Revenue · Operating Income